128 related articles for article (PubMed ID: 26394139)
1. CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.
Shamai S; Nabiochtchikov I; Kraus S; Zigdon S; Kazanov D; Itzhak-Klutch M; Eizner C; Arber N; Geva R
PLoS One; 2015; 10(9):e0134469. PubMed ID: 26394139
[TBL] [Abstract][Full Text] [Related]
2. Association of CD24 and the adenomatous polyposis coli gene polymorphisms with oral lichen planus.
Kaplan I; Nabiochtchikov I; Leshno A; Moshkowitz M; Shlomi B; Kleinman S; Dagan Y; Meshiach Y; Galazan L; Arber N; Avivi-Arber L; Kraus S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):378-85. PubMed ID: 26187149
[TBL] [Abstract][Full Text] [Related]
3. Role of CD24 polymorphisms in the susceptibility to inflammatory bowel disease.
Lisiansky V; Kraus S; Naumov I; Kazanov D; Nabiochtchikov I; Toledano O; Leshno M; Avivi D; Dotan I; Arber N; Moshkowitz M
Int J Biol Markers; 2014 Mar; 29(1):e62-8. PubMed ID: 24557789
[TBL] [Abstract][Full Text] [Related]
4. CD24 genetic variants contribute to overall survival in patients with gastric cancer.
Jia ZF; Wang LZ; Cao XY; Wang C; Cao DH; Wu X; You LL; Jin MS; Wang YP; Zhou BS; Jiang J
World J Gastroenterol; 2016 Feb; 22(7):2373-82. PubMed ID: 26900300
[TBL] [Abstract][Full Text] [Related]
5. CD24 polymorphisms cannot predict pathologic complete response to anthracycline- and taxane-based neoadjuvant chemotherapy in breast cancer.
Zhou X
Clin Breast Cancer; 2014 Apr; 14(2):e33-40. PubMed ID: 24393851
[TBL] [Abstract][Full Text] [Related]
6. Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival.
Smith JP; Whitcomb DC; Matters GL; Brand RE; Liao J; Huang YJ; Frazier ML
Pancreas; 2015 Mar; 44(2):236-42. PubMed ID: 25469546
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma.
Zhang L; Wu G; Herrle F; Niedergethmann M; Keese M
Cancer Genomics Proteomics; 2012; 9(5):287-95. PubMed ID: 22990108
[TBL] [Abstract][Full Text] [Related]
8. Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.
Hori Y; Miyabe K; Yoshida M; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Umemura S; Kato A; Ohara H; Inagaki H; Joh T
PLoS One; 2015; 10(3):e0118829. PubMed ID: 25734904
[TBL] [Abstract][Full Text] [Related]
9. The APC E1317Q and I1307K polymorphisms in non-colorectal cancers.
Liberman E; Kraus S; Sagiv E; Dulkart O; Kazanov D; Arber N
Biomed Pharmacother; 2007 Oct; 61(9):566-9. PubMed ID: 17920230
[TBL] [Abstract][Full Text] [Related]
10. Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects.
Abdel-Malak C; Darwish H; Elsaid A; El-Tarapely F; Elshazli R
Fam Cancer; 2016 Jan; 15(1):49-56. PubMed ID: 26314409
[TBL] [Abstract][Full Text] [Related]
11. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes for anaplastic pancreatic cancer: a population-based study.
Clark CJ; Graham RP; Arun JS; Harmsen WS; Reid-Lombardo KM
J Am Coll Surg; 2012 Nov; 215(5):627-34. PubMed ID: 23084492
[TBL] [Abstract][Full Text] [Related]
13. Effect of Adenomatous Polyposis Coli Loss on Tumorigenic Potential in Pancreatic Ductal Adenocarcinoma.
Cole JM; Simmons K; Prosperi JR
Cells; 2019 Sep; 8(9):. PubMed ID: 31540078
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
15. A vascular endothelial growth factor gene polymorphism predicts malignant potential in intraductal papillary mucinous neoplasm.
Yabusaki N; Yamada S; Shimoyama Y; Fujii T; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Pancreas; 2015 May; 44(4):608-14. PubMed ID: 25875799
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
17. CD24 polymorphisms in breast cancer: impact on prognosis and risk.
Buck K; Hug S; Seibold P; Ferschke I; Altevogt P; Sohn C; Schneeweiss A; Burwinkel B; Jäger D; Flesch-Janys D; Chang-Claude J; Marmé F
Breast Cancer Res Treat; 2013 Feb; 137(3):927-37. PubMed ID: 23314606
[TBL] [Abstract][Full Text] [Related]
18. No evidence of the APC D1822V missense variant's pathogenicity in Tunisian patients with sporadic colorectal cancer.
Bougatef K; Marrakchi R; Ouerhani S; Sassi R; Moussa A; Kourda N; Blondeau Lahely Y; Najjar T; Ben Jilani S; Soubrier F; Ben Ammar Elgaaied A
Pathol Biol (Paris); 2009 May; 57(3):e67-71. PubMed ID: 18343606
[TBL] [Abstract][Full Text] [Related]
19. Contribution of CD24 polymorphisms to autoimmune disease: A meta-analysis.
Baek J; Kang S; Byeon H; Woo Hwang K; Min H
Comput Biol Med; 2015 Sep; 64():268-75. PubMed ID: 26245161
[TBL] [Abstract][Full Text] [Related]
20. Effects of base excision repair gene polymorphisms on pancreatic cancer survival.
Li D; Li Y; Jiao L; Chang DZ; Beinart G; Wolff RA; Evans DB; Hassan MM; Abbruzzese JL
Int J Cancer; 2007 Apr; 120(8):1748-54. PubMed ID: 17230526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
